ReviewFrontiers in medicine2026
Ultra-widefield color fundus photography in diabetic retinopathy: from panretinal assessment to multimodal integration.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) is the leading cause of vision loss among working-age adults. Early screening and precise staging are crucial for delaying disease progression. Although the traditional Early Treatment of Diabetic Retinopathy Study (ETDRS) 7-field method is the gold standard for grading, it covers only 35% of the retinal area, carrying a risk of missing peripheral lesions. Ultra-widefield color fundus photography (UWF-CFP) overcomes this limitation by capturing up to 200° of the retina in a single image, enabling comprehensive visualization of peripheral ischemia, neovascularization, and peripheral-posterior pole asymmetry lesions. In recent years, combining UWF-CFP with deep learning algorithms has achieved robust performance in automated DR screening, grading, and quantitative vascular analysis. When further integrated with ultra-widefield swept-source optical coherence tomography angiography (UWF SS-OCTA) or multimodal clinical data, these AI-driven methods can improve diagnostic consistency and staging accuracy. Moreover, because the retinal microvasculature mirrors systemic microcirculation, vascular parameters from UWF-CFP have shown correlations with diabetic nephropathy, coronary artery calcification, and stroke risk, highlighting a potential role in non-invasive assessment of systemic complication risks in diabetic patients. UWF-CFP is facilitating a shift in the DR assessment paradigm from ETDRS 7-field to full retinal assessment. Combined with artificial intelligence and multimodal data integration, UWF-CFP has the potential to contribute to a future care model that integrates ocular and systemic risk assessment, which we tentatively term "eye-system collaborative management," though this paradigm remains to be validated in prospective studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.